SYN-TECH Chem. & Pharm. Co., Ltd. (TPEX:1777)
75.90
-1.20 (-1.56%)
Nov 6, 2026, 1:30 PM CST
SYN-TECH Chem. & Pharm. Revenue
SYN-TECH Chem. & Pharm. had revenue of 336.40M TWD in the quarter ending June 30, 2026, with 3.56% growth. This brings the company's total for the last twelve months to 1.27B, down -1.07% year-over-year. In the year 2025, SYN-TECH Chem. & Pharm. had annual revenue of 1.30B with 3.39% growth. That makes SYN-TECH Chem. & Pharm. the 29,696th largest company in the world by revenue and 1,443rd in Taiwan.
Revenue (ttm)
1.27B
Revenue Growth
-1.07%
P/S Ratio
2.66
Revenue / Employee
5.70M
Employees
223
Market Cap
3.38B
Revenue by Geography
- Asia (Excluding Taiwan) 730.60M 56.2%
- Taiwan 344.11M 26.5%
- Europe 173.99M 13.4%
- Other 27.24M 2.1%
- America 24.29M 1.9%
Fiscal year ended Dec 31, 2025 See the full SYN-TECH Chem. & Pharm. breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.30B | 42.58M | 3.39% |
| Dec 31, 2024 | 1.26B | 142.98M | 12.83% |
| Dec 31, 2023 | 1.11B | 128.39M | 13.02% |
| Dec 31, 2022 | 986.30M | 93.07M | 10.42% |
| Dec 31, 2021 | 893.23M | -90.56M | -9.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sagittarius Life Science | 467.69M |
| BioGend Therapeutics | 235.24M |
| Pharmosa Biopharm | 53.38M |
| Formosa Pharmaceuticals | 52.59M |
| Shine-On BioMedical | 50.62M |
| Intech Biopharm | 48.55M |
| BRIM Biotechnology | 10.60M |
| Great Novel Therapeutics Biotech & Medicals | 6.21M |